<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00800852</url>
  </required_header>
  <id_info>
    <org_study_id>2008-10-040</org_study_id>
    <nct_id>NCT00800852</nct_id>
  </id_info>
  <brief_title>Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome</brief_title>
  <official_title>Increased Expression of Adiponectin Receptor 2 in the Mononuclear Cells in Children With Prader-Willi Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The inflammatory process is involved in the pathogenesis of obesity. Prader-Willi syndrome&#xD;
      (PWS) is a genetic model of syndromic obesity. Adiponectin is an adipokine with potent&#xD;
      anti-inflammatory properties, and its effect is mediated through adiponectin receptors 1&#xD;
      (adipoR1) and 2 (adipoR2).&#xD;
&#xD;
      Objective of this study is to compare the expression of adipoR1, adipoR2, and adiponectin in&#xD;
      peripheral blood mononuclear cells (PBMCs) in PWS children and obese control and to correlate&#xD;
      receptor expression with insulin sensitivity and obesity-related parameters.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Obesity</condition>
  <condition>Prader-Willi Syndrome</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Fourteen children with PWS and control subjects&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  children with Prader-willi syndrome&#xD;
&#xD;
          -  children with simple obesity&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  subjects with diabetes mellitus (fasting plasma glucose &gt; 126 mg/dL with a 2-h oral&#xD;
             glucose tolerance test value of &gt;200 mg/dl)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Don-Kyu Jin, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center, Sungkyunkwan Uiversity School of Medicine</affiliation>
  </overall_official>
  <verification_date>November 2008</verification_date>
  <study_first_submitted>November 30, 2008</study_first_submitted>
  <study_first_submitted_qc>December 1, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2008</study_first_posted>
  <last_update_submitted>December 1, 2008</last_update_submitted>
  <last_update_submitted_qc>December 1, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2008</last_update_posted>
  <responsible_party>
    <name_title>Dong-Kyu Jin</name_title>
    <organization>Samsung Medical Center</organization>
  </responsible_party>
  <keyword>adiponectin</keyword>
  <keyword>adiponectin receptor</keyword>
  <keyword>Prader-Willi syndrome</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prader-Willi Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

